Compounds > phenylethyl alcohol
Page last updated: 2024-08-17

phenylethyl alcohol and Eczema, Atopic

phenylethyl alcohol has been researched along with Eczema, Atopic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jamil, A; Katas, H; Mohd Amin, MCI; Nadeem, SM; Ng, SF; Siddique, MI; Zulfakar, MH1
Hussain, Z; Katas, H; Kumolosasi, E; Mohd Amin, MC1
Bae, ON; Bae, S; Kim, ES; Koo, JE; Lee, JY; Lim, KM1
Amin, MC; Jamil, A; Katas, H; Ng, SF; Siddique, MI; Zulfakar, MH1
Buang, F; Hussain, Z; Katas, H; Kumolosasi, E; Mohd Amin, MC; Sahudin, S1

Trials

1 trial(s) available for phenylethyl alcohol and Eczema, Atopic

ArticleYear
Potential treatment of atopic dermatitis: tolerability and safety of cream containing nanoparticles loaded with hydrocortisone and hydroxytyrosol in human subjects.
    Drug delivery and translational research, 2019, Volume: 9, Issue:2

    Topics: Administration, Cutaneous; Adolescent; Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Dermatitis, Atopic; Double-Blind Method; Female; Glucocorticoids; Humans; Hydrocortisone; Middle Aged; Nanoparticles; Phenylethyl Alcohol; Skin; Skin Cream; Young Adult

2019

Other Studies

4 other study(ies) available for phenylethyl alcohol and Eczema, Atopic

ArticleYear
Efficient immuno-modulation of TH1/TH2 biomarkers in 2,4-dinitrofluorobenzene-induced atopic dermatitis: nanocarrier-mediated transcutaneous co-delivery of anti-inflammatory and antioxidant drugs.
    PloS one, 2014, Volume: 9, Issue:11

    Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Dinoprostone; Disease Models, Animal; Drug Carriers; Histamine; Hydrocortisone; Immunoglobulin E; Mice; Nanoparticles; Phenylethyl Alcohol; Skin; Th1 Cells; Th2 Cells; Vascular Endothelial Growth Factor A

2014
Suppression of skin inflammation in keratinocytes and acute/chronic disease models by caffeic acid phenethyl ester.
    Archives of dermatological research, 2015, Volume: 307, Issue:3

    Topics: Acute Disease; Animals; Caffeic Acids; Cell Line; Chronic Disease; Cyclooxygenase 2; Dermatitis, Atopic; Disease Models, Animal; Humans; Immunoglobulin E; Inflammation; Keratinocytes; Mice; Mice, Inbred Strains; NF-kappa B; Oxazolone; Phenylethyl Alcohol; Propolis; Skin; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Water Loss, Insensible

2015
In-vivo dermal pharmacokinetics, efficacy, and safety of skin targeting nanoparticles for corticosteroid treatment of atopic dermatitis.
    International journal of pharmaceutics, 2016, Jun-30, Volume: 507, Issue:1-2

    Topics: Animals; Anti-Inflammatory Agents; Chitosan; Dermatitis, Atopic; Drug Delivery Systems; Hydrocortisone; Nanoparticles; Particle Size; Phenylethyl Alcohol; Rats; Skin; Skin Absorption

2016
Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone/hydroxytyrosol: an ex vivo and in vivo study using an NC/Nga mouse model.
    International journal of pharmaceutics, 2013, Feb-28, Volume: 444, Issue:1-2

    Topics: Animals; Anti-Inflammatory Agents; Chitosan; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Drug Carriers; Hydrocortisone; Mice; Nanoparticles; Phenylethyl Alcohol; Skin; Skin Absorption

2013